Biotechnology | CRISPR | Disease | FDA | Genomics | Stem Cell | Therapeutics
FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease
On Dec. 8, 2025, the U.S. Food and Drug Administration (FDA) approved two milestone treatments, Casgevy and Lyfgenia,…